Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the biosimilar hormones market grown over the years?

In recent years, the size of the biosimilar hormones market has seen exponential expansion. We foresee an increase from $3.9 billion in 2024 to $4.98 billion in 2025, marking a compound annual growth rate (CAGR) of 27.5%. The notable growth observed in the historical period is linked to factors such as the escalating occurrence of chronic illnesses, an increasing aging population, heightened awareness of biosimilar hormones, and broader access to healthcare services.

What Is the forecasted market size and growth rate for the biosimilar hormones market?

The market size of biosimilar hormones is predicted to witness significant surge in the near future, reaching $11.77 billion in 2029 with a compound annual growth rate (CAGR) of 24.0%. Factors contributing to this projected growth during the forecast period include increased hormone targets, enhanced patient approval, progression in production technology, governmental backing, abundant clinical trial findings, and extensive access to healthcare facilities. Key trends projected in the forecast period encompass individualized hormone replacement, introduction of new products, pricing and accessibility, and patient-focused care.

Get your biosimilar hormones market report here!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3432&type=smp

What are the major factors driving growth in the biosimilar hormones market?

The hormone biosimilar market is impacting the prevalence of growth hormone and metabolic hormone deficiencies. Over time, the treatments for hormone-related issues have developed and advanced, increasing the demand for hormone biosimilar due to the prevalent hormonal deficiencies. For example, as cited in the British Medical Journal, a UK-based peer-reviewed medical trade publication, in January 2022, the GH deficiency’s prevalence is speculated to oscillate between 1 in every 3500 and 1 in 10000 children worldwide. Furthermore, a Medscape report from June 2022 anticipates that approximately 6,000 adults in the USA will be diagnosed with a growth hormone deficiency. This escalating demand to address patients with prevailing hormone deficiencies is serving as a catalyst for the growth of the biosimilar hormones market.

What key areas define the segmentation of the global biosimilar hormones Market?

The biosimilar hormones market covered in this report is segmented –

1) By Type: Teriparatide Biosimilars, Follitropin Alfa Biosimilars, Insulin Biosimilars, Somatropin Biosimilars, Other Types

2) By Application: Research & Biotechnology, Diagnostics, Biocatalysts, Therapeutics, Other Applications

3) By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/pharmacy, Specialty Clinics

Subsegments:

1) By Teriparatide Biosimilars: Osteoporosis Treatment, Bone Health Maintenance

2) By Follitropin Alfa Biosimilars: Infertility Treatment, Assisted Reproductive Technology (ART)

3) By Insulin Biosimilars: Type 1 Diabetes Management, Type 2 Diabetes Management

4) By Somatropin Biosimilars: Growth Hormone Deficiency Treatment, Pediatric Growth Disorders

5) By Other Types: Thyroid Hormones, Corticosteroids

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3432&type=smp

What are the top market players propelling the growth of the biosimilar hormones industry?

Major companies operating in the biosimilar hormones market include Teva Pharmaceutical Industries Ltd., Gedeon Richter Plc., Intas Pharmaceuticals Ltd., Biocon Limited, Mylan, Sanofi, Sandoz Group AG, LG Life Sciences, Ferring Pharmaceuticals, GC Pharma, Pfizer Inc., Dr. Reddy’s Laboratories, Amgen Inc., Eli Lilly and Company, Celltrion Inc., Samsungbioepis Co.Ltd, Merck & Co., Biogen Inc., Boehringer Ingelheim, Alvotech, BioXpress Therapeutics, Cipla Limited, Lupin Ltd., Stada Arzneimittel AG, Torrent Pharmaceuticals, Zydus Cadila, Accord Healthcare, Hetero Drugs, Wockhardt

What are the key trends shaping the future of the biosimilar hormones market?

Major players in the biosimilar hormones market are utilizing strategic methods like launching novel products in untapped regions to extend their reach and serve a more extensive populace. Their main aim is to enhance sales and increase earning profits by making their products accessible in diverse locations. For example, Alvotech Holdings S.A., a biopharmaceutical firm based in Luxembourg that concentrates on biosimilar medicines development, announced collaborations with Fuji Pharma Co. Ltd., a pharmaceutical firm from Japan, for the development of biosimilar drug candidates in Japan in February 2022. In this collaboration, both firms have opted to introduce new aspects in their strategic alliance to create and promote biosimilar medicines in Japan.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3432

What regions are dominating the biosimilar hormones market growth?

North America was the largest region in the biosimilar hormones market in 2024. The regions covered in the biosimilar hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:

Anti-Thyroid Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

Branded Generics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/branded-generics-global-market-report

G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/g-csf-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: